Patents by Inventor Michal L. Peri

Michal L. Peri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7660449
    Abstract: A method for measuring residual protein in a cellular specimen including obtaining a low magnification image of a candidate object of interest, filtering the candidate object of interest pixels with a low pass filter, morphologically processing the candidate object of interest pixels to identify artifact pixels, identifying the candidate object of interest by eliminating artifact pixels, acquiring a higher magnification image of the subsample for the candidate object of interest, transforming pixels of the higher magnification image in a first color space to a second color space to differentiate higher magnification candidate object of interest pixels from background pixels, identifying an object of interest from the candidate object of interest pixels in the second color space, and determining the optical density of the protein in a cell contained in a subsample, wherein the optical density is indicative of the residual component of a cellular protein.
    Type: Grant
    Filed: April 14, 2008
    Date of Patent: February 9, 2010
    Assignee: Carl Zeiss MicroImaging GmbH
    Inventors: Presley Hays, Michal L. Peri, Douglas Harrington
  • Publication number: 20080260233
    Abstract: A method for measuring residual protein in a cellular specimen including obtaining a low magnification image of a candidate object of interest, filtering the candidate object of interest pixels with a low pass filter, morphologically processing the candidate object of interest pixels to identify artifact pixels, identifying the candidate object of interest by eliminating artifact pixels, acquiring a higher magnification image of the subsample for the candidate object of interest, transforming pixels of the higher magnification image in a first color space to a second color space to differentiate higher magnification candidate object of interest pixels from background pixels, identifying an object of interest from the candidate object of interest pixels in the second color space, and determining the optical density of the protein in a cell contained in a subsample, wherein the optical density is indicative of the residual component of a cellular protein.
    Type: Application
    Filed: April 14, 2008
    Publication date: October 23, 2008
    Applicant: Carl Zeiss Microlmaging AIS, Inc.
    Inventors: Presley Hays, Michal L. Peri, Douglas Harrington
  • Patent number: 7359536
    Abstract: An automated method for evaluating the amount of residual protein levels following treatment of cellular specimens. Particular methods include the measurement of maternal neutrophil alkaline phosphatase after treatment with or without urea or heat, measurement of leukocyte acid phosphatase after treatment with or without tartrate, and measurement of leukocyte esterase after treatment with ?-naphthol butyrate with or without fluoride.
    Type: Grant
    Filed: December 5, 2003
    Date of Patent: April 15, 2008
    Assignee: Carl Zeiss MicroImaging AIS, Inc.
    Inventors: Presley Hays, Michal L. Peri, Douglas Harrington
  • Publication number: 20040120562
    Abstract: An automated method for evaluating the amount of residual protein levels following treatment of cellular specimens. Particular methods include the measurement of maternal neutrophil alkaline phosphatase after treatment with or without urea or heat, measurement of leukocyte acid phosphatase after treatment with or without tartrate, and measurement of leukocyte esterase after treatment with &agr;-naphthol butyrate with or without fluoride.
    Type: Application
    Filed: December 5, 2003
    Publication date: June 24, 2004
    Inventors: Presley Hays, Michal L. Peri, Douglas Harrington
  • Patent number: 6671393
    Abstract: An automated method for evaluating the amount of residual protein levels following treatment of cellular specimens. Particular methods include the measurement of maternal neutrophil alkaline phosphatase after treatment with or without urea or heat, measurement of leukocyte acid phosphatase after treatment with or without tartrate, and measurement of leukocyte esterase after treatment with &agr;-naphthol butyrate with or without fluoride.
    Type: Grant
    Filed: December 10, 2001
    Date of Patent: December 30, 2003
    Assignee: ChromaVision Medical Systems, Inc.
    Inventors: Presley Hays, Michal L. Peri, Douglas Harrington
  • Publication number: 20020176613
    Abstract: An automated method for evaluating the amount of residual protein levels following treatment of cellular specimens. Particular methods include the measurement of maternal neutrophil alkaline phosphatase after treatment with or without urea or heat, measurement of leukocyte acid phosphatase after treatment with or without tartrate, and measurement of leukocyte esterase after treatment with &agr;-naphthol butyrate with or without fluoride.
    Type: Application
    Filed: December 10, 2001
    Publication date: November 28, 2002
    Inventors: Presley Hays, Michal L. Peri, Douglas Harrington
  • Patent number: 6330349
    Abstract: An automated method for evaluating the amount of residual protein levels following treatment of cellular specimens. Particular methods include the measurement of maternal neutrophil alkaline phosphatase after treatment with or without urea or heat, measurement of leukocyte acid phosphatase after treatment with or without tartrate, and measurement of leukocyte esterase after treatment with &agr;-naphthol butyrate with or without fluoride.
    Type: Grant
    Filed: July 7, 2000
    Date of Patent: December 11, 2001
    Assignee: ChromaVision Medical Systems, Inc.
    Inventors: Presley Hays, Michal L. Peri, Douglas Harrington